Skip to main content
Equibles

LOS ANGELES CAPITAL MANAGEMENT LLC

Position in EBS — Emergent BioSolutions Inc.

CIK 1177206 LOS ANGELES, CA
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$216,237
-$360,521 QoQ
Shares Held
25,804
-62.9% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 194 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $64,712,202 across 30 Drug Manufacturers - Specialty & Generic names. EBS ranks #14 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 203,548 $34,305,979
2 VTRS
Viatris Inc
 751,406 $11,932,327
3 LQDA
Liquidia Corp
 54,603 $4,353,497
4 KNSA
Kiniksa Pharmaceuticals International, plc
 50,786 $3,247,764
5 COLL
Collegium Pharmaceutical, Inc
 89,443 $3,237,836
6 PAHC
Phibro Animal Health Corp
 67,083 $2,106,406
7 IRWD
Ironwood Pharmaceuticals Inc
 342,293 $1,441,053
8 AKBA
Akebia Therapeutics, Inc.
 531,813 $606,266

All Filings in EBS

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $216,237 25,804
2026-03-31 $576,758 69,489
2025-12-31 $876,546 70,918
2025-09-30 $1,189,818 134,900
2024-06-30 $1,219,688 178,840
2024-03-31 $490,797 193,991
2023-12-31 $387,674 161,531
2023-09-30 $587,231 172,715
2023-06-30 $659,434 89,719
2023-03-31 $460,647 44,464
2021-12-31 $379,623 8,733
2021-09-30 $882,483 17,625
2021-06-30 $577,303 9,165
2021-03-31 $828,292 8,915
2020-12-31 $1,309,952 14,620
2020-09-30 $1,533,313 14,839
2020-06-30 $1,138,672 14,399
2020-03-31 $936,406 16,184